Innovative biopharmaceutical company focusing on antibody drugs-Sunshine Guojian

Leader of Antibody Drugs in China

Benefit China and embrace the world, making innovative antibody drugs within reach.
Systematic Innovation Capability

Multiple technical platforms for innovative antibody drugs, over 14 years of experience in industrial-scale antibody production.
Patient-oriented

Provide high-quality, safe and effective clinical solutions to contribute to Healthy China.

Sunshine Guojian always gives top priority to production safety.
Since May 1, 2005, we have maintained safe production fordays.

Leader of Antibody Drugs in China

Benefit China and embrace the world, making innovative antibody drugs within reach.
Systematic Innovation Capability

Multiple technical platforms for innovative antibody drugs, over 14 years of experience in industrial-scale antibody production.
Patient-oriented

Provide high-quality, safe and effective clinical solutions to contribute to Healthy China.

Sunshine Guojian always gives top priority to production safety. Since May 1, 2005, we have maintained safe production fordays.

Our drug R&D always focuses on technology, innovation and internationalization.

Covering the whole process of drug development, ranging from basic research, pre-clinical research, clinical trials to new drug registration and marketing.

Learn More

Our Technology

All what we do is to meet the demands of patients.

Focusing on the development of antibody drugs, with a variety of leading antibody products at different stages of development.

Learn More

Our Products

Working together to make the world healthier.

Always focusing on high-quality drugs to improve the quality of life of patients for the benefit of human health.

Learn More

Our Responsibilities

News Center

Creating a win-win situation between corporate growth and employee career development.

Advocating work-life balance, and ensuring all employees in Sunshine Guojian feel they are valued for and proud of what they’ve achieved.

Learn More

Career Development

百度搜狗 360搜索沪电股份：预计一季度净利润同比增长39.86%-59.28% 指示牌引发争议，国产游戏《鸣潮》道歉耿爽：中方为国际和平安全贡献力量水枪大测评：600元开箱7款玩具水枪，试试哪个最好玩？股民押中农业股1天从亏5万到赚5万

~~<i id='08da3'><strike id='84446'><tt id='55672'><pre id='dbb5d'></pre></tt></strike></i>~~

Leader of Antibody Drugs in China

Benefit China and embrace the world, making innovative antibody drugs within reach.

Systematic Innovation Capability

Multiple technical platforms for innovative antibody drugs, over 14 years of experience in industrial-scale antibody production.

Patient-oriented

Provide high-quality, safe and effective clinical solutions to contribute to Healthy China.

Sunshine Guojian always gives top priority to production safety.
Since May 1, 2005, we have maintained safe production fordays.

Leader of Antibody Drugs in China

Benefit China and embrace the world, making innovative antibody drugs within reach.

Systematic Innovation Capability

Multiple technical platforms for innovative antibody drugs, over 14 years of experience in industrial-scale antibody production.

Patient-oriented

Provide high-quality, safe and effective clinical solutions to contribute to Healthy China.

Sunshine Guojian always gives top priority to production safety. Since May 1, 2005, we have maintained safe production fordays.

Our drug R&D always focuses on technology, innovation and internationalization.

All what we do is to meet the demands of patients.

Working together to make the world healthier.

2020-06-28

Sunshine Guojian obtained clinical trial approval by the FDA for the anti-IL-4Rα monoclonal antibody

2020-06-19

Breaking the monopoly of imported anti-HER2 monoclonal antibody drugs Approval obtained for “Inetetamab”, the first innovative anti-HER2 monoclonal antibody independently developed in China

2020-01-10

Sunshine Guojian Pharmaceutical (Shanghai) Co., Ltd. Constructs Shanghai Technology Innovation Center of Antibodies

Creating a win-win situation between corporate growth and employee career development.